TABLE 3.
Clinical and microbiological characteristics of ESBL-producing hvKP isolates
| Clinical characteristic | Value for patient isolate: |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |
| Age (yr) | 76 | 76 | 49 | 43 | 60 | 53 | 20 | 53 | 62 | 48 | 1 mo |
| Gender | Male | Male | Male | Female | Female | Male | Female | Male | Female | Female | Male |
| City | Shanghai | Guangzhou | Guangzhou | Shenyang | Shenyang | Shenyang | Tianjin | Xi'an | Beijing | Jinan | Wuhan |
| Specimen type | Blood | Sputum | Sputum | Bile | Bile | Blood | Blood | Blood | Blood | Blood | Blood |
| Date of specimen collection (yr/mo/day) | 2013/4/13 | 2013/4/2 | 2013/3/6 | 2013/1/31 | 2013/2/18 | 2013/1/29 | 2013/3/17 | 2013/2/25 | 2013/7/23 | 2013/7/26 | 2013/3/26 |
| Infection type | Septicemia | Pneumonia | Pneumonia | Liver abscess | Abdominal infection | Liver abscess | Septicemia | Bacteremia | Septicemia | Bacteremia | Septicemia |
| Clinical outcome | Survived | Survived | Survived | Unknown | Unknown | Unknown | Survived | Survived | Survived | Survived | Survived |
| β-Lactamase(s) | SHV-75, CTX-M-55 | SHV-11, TEM-1, CTX-M-55 | SHV-11, TEM-1, CTX-M-55 | SHV-11, TEM-1, CTX-M-like | SHV-11, TEM-1, CTX-M-like | SHV-11, TEM-1, CTX-M-like | SHV-148 | CTX-M-14 | SHV-11, CTX-M-14 | CTX-M-14 | SHV-11, TEM-53 |
| Virulence-associated features | |||||||||||
| String test | + | − | + | + | + | + | + | + | + | − | + |
| cps genotyping | K20 | K1 | K1 | K1 | K20 | K20 | K2 | K1 | K nontypeable | K nontypeable | K2 |
| rmpA gene | + | + | + | + | + | + | + | + | + | + | + |
| MLST | ST420 | ST23 | ST23 | ST268 | ST268 | ST268 | ST1658 | ST367 | ST17 | ST35 | ST65 |